Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021
Summary Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Keratoconjunctivitis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Keratoconjunctivitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Keratoconjunctivitis and features dormant and discontinued projects.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope - The report provides a snapshot of the Global Therapeutic Landscape of Keratoconjunctivitis (Ophthalmology). - The report reviews pipeline therapeutics for Keratoconjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The report covers pipeline products based on various stages of development ranging from discovery till pre-registration. - The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities. - The report reviews key players involved in the development of Keratoconjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects. - The report assesses Keratoconjunctivitis (Ophthalmology) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. - The report summarizes all the dormant and discontinued pipeline projects. - The report reviews latest news related to pipeline therapeutics for Keratoconjunctivitis (Ophthalmology).
Reasons to Buy - Gain strategically significant competitor information, analysis, and insights to formulate effective Research and Development (R&D) strategies. - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Identify and understand important and diverse types of therapeutics under development for Keratoconjunctivitis (Ophthalmology). - Identify potential new clients or partners in the target demographic. - Develop strategic initiatives by understanding the focus areas of leading companies. - Plan Mergers and Acquisitions (M&A) effectively by identifying key players and it’s most promising pipeline therapeutics. - Devise corrective measures for pipeline projects by understanding Keratoconjunctivitis (Ophthalmology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Our reports have been used by over 10K customers, including:
The analyst presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the market’s maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations...
The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...
175 pages •
By The Business Research Company
• May 2021
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center, and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $16.948 billion in 2020 to $18.475...
The global medical tourism market is expected to exhibit strong growth during 2021-2026. Medical tourism refers to organized travel across countries to receive medical treatment. It usually involves traveling abroad for maintenance, enhancement or restoration of health through advanced healthcare facilities and treatment...
This IDC study discusses how healthcare organizations are on a mission to digitally transform to create a value-based healthcare system, even though they may not use the term digital transformation as extensively as other industries such as retail or financial services do. While the pandemic drove unprecedented adoption of virtual visits and...
The global fertility services market exhibited strong growth during 2015-2020. Fertility services refer to the procedures provided as a treatment for infertility. Infertility is defined as the inability to conceive or carry a full-term pregnancy. Among males, it is identified by a low sperm count or is a result of hormonal...
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Electroencephalography (EEG) Devices Market 2021-2025 The analyst has been monitoring the electroencephalography (EEG) devices market and it is poised to grow by USD 444.18 million during 2021-2025, progressing at a CAGR of over 9% during the forecast period. Our report on the electroencephalography (EEG) devices...
Hip Replacement Market, Global Forecast, Impact of Coronavirus, Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis Hip replacement is a minimally invasive surgical procedure to replace a hip joint with a prosthetic implant. It is a general surgery that helps to minimize pain...
398 pages •
By Global Industry Analysts
• May 2021
Global Electrosurgery Market to Reach US$6.3 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Electrosurgery estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$6.3 Billion by 2027, growing at a CAGR of 3.7% over the analysis...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.